Career history of Raphael J. Mannino
Former positions of Raphael J. Mannino
| Companies | Position | Start | End |
|---|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2015 | 10/08/2022 |
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 31/12/1989 | 31/07/2015 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director/Board Member | 31/12/1999 | 31/12/2006 |
| Chief Tech/Sci/R&D Officer | 31/12/2000 | 31/12/2008 | |
| Founder | 31/12/1994 | 31/12/2008 | |
| Albany Medical College | Corporate Officer/Principal | 31/12/1979 | 31/12/1989 |
| New Jersey Medical School | Corporate Officer/Principal | 31/12/1979 | 31/12/1979 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Director/Board Member | 31/05/2003 | - |
| Independent Dir/Board Member | 31/05/2003 | - |
Training of Raphael J. Mannino
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Stock Market
- Insiders
- Raphael J. Mannino
- Experience
